Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia
- 1 October 2007
- journal article
- case report
- Published by Elsevier in Archives of Medical Research
- Vol. 38 (7) , 797-802
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A new case of CD7-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired abnormalityCancer Genetics and Cytogenetics, 2002
- Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemiaCancer Genetics and Cytogenetics, 2001
- Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndromeLeukemia Research, 1999
- A new case of trisomy 21 in a patient with an acute nonlymphocytic leukemia (M5b)Cancer Genetics and Cytogenetics, 1997
- Trisomy 21 in acute myeloid leukemiaCancer Genetics and Cytogenetics, 1996
- Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study GroupBlood, 1994
- Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma [see comments]Blood, 1993
- Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children [see comments]Blood, 1992
- Prognostic value of lymphocyte surface markers in acute myeloid leukemia [see comments]Blood, 1991
- CD9 antigen on acute non-lymphoid leukemia cells: Preferential expression by promyelocytic (M3) subtypeLeukemia Research, 1991